Randomized controlled trial of toremifene 120 mg compared with exemestane 25 mg after prior treatment with a non-steroidal aromatase inhibitor in postmenopausal women with hormone receptor-positive metastatic breast cancer

BACKGROUND: After the failure of a non-steroidal aromatase inhibitor (nsAI) for postmenopausal patients with metastatic breast cancer (mBC), it is unclear which of various kinds of endocrine therapy is the most appropriate. A randomized controlled trial was performed to compare the efficacy and safe...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Yamamoto, Yutaka, Ishikawa, Takashi, Hozumi, Yasuo, Ikeda, Masahiko, Iwata, Hiroji, Yamashita, Hiroko, Toyama, Tatsuya, Chishima, Takashi, Saji, Shigehira, Yamamoto-Ibusuki, Mutsuko, Iwase, Hirotaka
التنسيق: Artigo
اللغة:Inglês
منشور في: BioMed Central 2013
الموضوعات:
Research Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC3661372/
https://ncbi.nlm.nih.gov/pubmed/23679192
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-13-239
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة